MA24607A1 - Compositions comprenant un sensibilisant a l'insuline, un secretagogue d'insuline et un biguanide antihyperglycemique - Google Patents

Compositions comprenant un sensibilisant a l'insuline, un secretagogue d'insuline et un biguanide antihyperglycemique

Info

Publication number
MA24607A1
MA24607A1 MA25171A MA25171A MA24607A1 MA 24607 A1 MA24607 A1 MA 24607A1 MA 25171 A MA25171 A MA 25171A MA 25171 A MA25171 A MA 25171A MA 24607 A1 MA24607 A1 MA 24607A1
Authority
MA
Morocco
Prior art keywords
insulin
compositions
secretagog
sensitizer
antihyperglycemic biguanide
Prior art date
Application number
MA25171A
Other languages
English (en)
Inventor
Stephen Alistair Smith
Robin Edwin Buckingham
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA24607A1 publication Critical patent/MA24607A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
MA25171A 1997-07-18 1998-07-16 Compositions comprenant un sensibilisant a l'insuline, un secretagogue d'insuline et un biguanide antihyperglycemique MA24607A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715295A GB9715295D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
MA24607A1 true MA24607A1 (fr) 1999-04-01

Family

ID=10816167

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25171A MA24607A1 (fr) 1997-07-18 1998-07-16 Compositions comprenant un sensibilisant a l'insuline, un secretagogue d'insuline et un biguanide antihyperglycemique

Country Status (40)

Country Link
EP (1) EP1001783B1 (fr)
JP (2) JP2001510159A (fr)
KR (1) KR100671918B1 (fr)
CN (1) CN1264303A (fr)
AP (1) AP1352A (fr)
AR (1) AR016349A1 (fr)
AT (1) ATE305790T1 (fr)
AU (1) AU8448898A (fr)
BG (1) BG64785B1 (fr)
BR (1) BR9810445A (fr)
CA (1) CA2296653C (fr)
CO (1) CO4940420A1 (fr)
CY (1) CY1105254T1 (fr)
DE (1) DE69831808T2 (fr)
DK (1) DK1001783T3 (fr)
DZ (1) DZ2562A1 (fr)
EA (1) EA003021B1 (fr)
ES (1) ES2251093T3 (fr)
GB (1) GB9715295D0 (fr)
HK (1) HK1028550A1 (fr)
HU (1) HUP0003629A3 (fr)
ID (1) ID24211A (fr)
IL (1) IL134046A0 (fr)
IN (1) IN189275B (fr)
MA (1) MA24607A1 (fr)
MY (1) MY155219A (fr)
NO (1) NO325727B1 (fr)
NZ (2) NZ501164A (fr)
OA (1) OA11279A (fr)
PE (1) PE99599A1 (fr)
PL (2) PL198017B1 (fr)
SA (1) SA98190468B1 (fr)
SI (1) SI1001783T1 (fr)
SK (1) SK285484B6 (fr)
TR (1) TR200000134T2 (fr)
TW (1) TW505516B (fr)
UA (1) UA70303C2 (fr)
UY (1) UY25102A1 (fr)
WO (1) WO1999003477A1 (fr)
ZA (1) ZA986363B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
IL143002A0 (en) * 1998-11-12 2002-04-21 Smithkline Beecham Plc Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
SE9902918D0 (sv) * 1999-08-13 1999-08-13 Pharmacia & Upjohn Ab Methods for identification of compounds stimulating insulin secretion
AR030920A1 (es) * 1999-11-16 2003-09-03 Smithkline Beecham Plc Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
EP1231917A2 (fr) * 1999-11-16 2002-08-21 Smithkline Beecham Plc Composition pharmaceutique a base d'hydrochloride de thiazolidinedione-metformine
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
ITFI20010126A1 (it) * 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
EP1429747A4 (fr) * 2001-07-10 2005-01-05 Kos Life Sciences Inc Preparation de noyau comprenant un hydrochlorure de pioglitazone et un biguanide
EP1515701B1 (fr) 2002-06-17 2014-09-17 Inventia Healthcare Private Limited Procédé de fabrication de comprimés multicouches comprenant de la thiazolidinedione et du biguanide
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
WO2005041962A1 (fr) 2003-10-31 2005-05-12 Takeda Pharmaceutical Company Limited Preparation solide comprenant un sensibilisateur a l'insuline, un secretagogue d'insuline et un ester d'acide gras de polyoxyethylene sorbitan
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101417130B (zh) * 2007-10-22 2010-10-06 鲁南制药集团股份有限公司 一种治疗ⅱ型糖尿病及其并发症的药物组合物
KR102176069B1 (ko) * 2017-10-20 2020-11-09 주식회사 노브메타파마 아연염, 시클로-히스프로 및 항당뇨 약물을 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학적 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1989008651A1 (fr) * 1988-03-08 1989-09-21 Pfizer Inc. Derives de thiaxolidinedione hypoglycemiques
WO1991007107A1 (fr) * 1989-11-13 1991-05-30 Pfizer Inc. Agents d'oxazolidinedione hypoglycemiques
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
WO1993003724A1 (fr) * 1991-08-26 1993-03-04 The Upjohn Company Composition pharmaceutique contenant de l'acide 3-guanidinopropionique ainsi que du glibenclamide ou glimepiride de pioglitazone
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
EP2266576A1 (fr) * 1997-06-18 2010-12-29 SmithKline Beecham Limited Traitement du diabete avec du thiazolidinedione et de la sulfonyluree

Also Published As

Publication number Publication date
AP1352A (en) 2004-12-24
AR016349A1 (es) 2001-07-04
CY1105254T1 (el) 2010-03-03
EP1001783B1 (fr) 2005-10-05
DE69831808T2 (de) 2006-07-06
CN1264303A (zh) 2000-08-23
DE69831808D1 (de) 2006-02-16
CA2296653C (fr) 2007-10-02
WO1999003477A1 (fr) 1999-01-28
DZ2562A1 (fr) 2003-02-15
UY25102A1 (es) 2000-12-29
MY155219A (en) 2015-09-30
IN189275B (fr) 2003-01-25
CA2296653A1 (fr) 1999-01-28
EP1001783A1 (fr) 2000-05-24
BG104135A (en) 2000-10-31
IL134046A0 (en) 2001-04-30
TR200000134T2 (tr) 2000-09-21
PL338126A1 (en) 2000-09-25
AP2000001733A0 (en) 2000-03-31
BR9810445A (pt) 2000-09-05
NZ511608A (en) 2002-12-20
GB9715295D0 (en) 1997-09-24
NZ501164A (en) 2001-06-29
DK1001783T3 (da) 2006-02-06
PL197844B1 (pl) 2008-05-30
SI1001783T1 (sl) 2006-02-28
ATE305790T1 (de) 2005-10-15
ID24211A (id) 2000-07-13
EA200000139A1 (ru) 2000-06-26
KR20010021947A (ko) 2001-03-15
SA98190468B1 (ar) 2007-01-20
NO20000228D0 (no) 2000-01-17
TW505516B (en) 2002-10-11
UA70303C2 (uk) 2004-10-15
ZA986363B (en) 2000-01-17
NO325727B1 (no) 2008-07-07
KR100671918B1 (ko) 2007-01-22
CO4940420A1 (es) 2000-07-24
AU8448898A (en) 1999-02-10
SK592000A3 (en) 2000-09-12
PL198017B1 (pl) 2008-05-30
JP2005213273A (ja) 2005-08-11
OA11279A (en) 2003-07-31
SK285484B6 (sk) 2007-02-01
PE99599A1 (es) 1999-12-18
ES2251093T3 (es) 2006-04-16
NO20000228L (no) 2000-01-17
EA003021B1 (ru) 2002-12-26
HUP0003629A2 (hu) 2001-07-30
JP2001510159A (ja) 2001-07-31
HUP0003629A3 (en) 2003-04-28
HK1028550A1 (en) 2001-02-23
BG64785B1 (bg) 2006-04-28

Similar Documents

Publication Publication Date Title
MA24607A1 (fr) Compositions comprenant un sensibilisant a l'insuline, un secretagogue d'insuline et un biguanide antihyperglycemique
FR2719997B1 (fr) Dispositif à timbre de délivrance transcutanée d'insuline.
NO20002038D0 (no) Uløselig insulinsammensetning
FR2721215B1 (fr) Formulations d'analogues monomères de l'insuline.
FR2767626B1 (fr) Terminal radiotelephonique a carte d'identification d'abonne
EP0621714A3 (fr) Plate-forme pour services d'information.
FR2719242B1 (fr) Pompe à précompression perfectionnée.
DE69808399D1 (de) Tabletten mit verlängerter Wirkstofffreisetzung (insbesondere von Pseudoephedrine Hydrochlorid)
ZA9811559B (en) Fungicidal mixtures based on amide compounds and tetrachloriosophthal onitrile.
PT1047300E (pt) Misturas fungicidas a base de compostos amida e de azois
ITMI911395A1 (it) Soluzioni erbicide a base di n-fosfonometilglicina
FR2791985B1 (fr) Composition a base de 2-cyanoacrylate et adhesif, charge et materiau d'empotage comprenant cette composition
DE68904088D1 (de) Spender fuer sonobojen.
FR2737086B1 (fr) Composition fongicide comprenant un compose analogue de la strobilurine
HUP0100456A3 (en) Ifnar2/ifn complex
MA24608A1 (fr) Compositions contenant un sensibilisant a l'insuline, un secretagogue d'insuline et un agent anti-heperglycemique inhibiteur d'alphat-glugosidase.
ZA984826B (en) Novel anti-diabetic composition.
MA24571A1 (fr) Compositions comprenant un sensibilisant a l'insuline et un secretagogue d'insuline pour une methode de traitement
TR27782A (tr) Bir fenilbenzamid'e dayanan fungisidal birlesimler.
MA23426A1 (fr) Composition fongicide a base d'iprodione et d'un compose triazole.
IT1295369B1 (it) Composizione a base di tiamfenicolo e diclofenac
IT215967Z2 (it) Cremagliera a segmenti modulari in nylon stampati su un'anima metallica.
FR2732190B1 (fr) Composition fongicide a base de prochloraze et d'un compose triazole
FR2759175B1 (fr) Dispositif de desembrouillage d'element de securite et element de securite comprenant un tel dispositif
FR2704343B1 (fr) Machine à affranchir en deux parties.